The global market for Rabies Vaccine was estimated to be worth US$ 931 million in 2023 and is forecast to a readjusted size of US$ 1229.1 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030

Rabies Vaccine - Market

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Rabies Vaccine by region & country, by Type, and by Application.

The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.

Market Segmentation

Scope of Rabies Vaccine - Market Report

Report Metric	Details
Report Name	Rabies Vaccine - Market
Forecasted market size in 2030	US$ 1229.1 million
CAGR	4.0%
Forecasted years	2024 - 2030
Segment by Type:	Vero Cell Rabies Vaccine BHK Chick Embryo Cell Rabies Vaccine Others
Segment by Application	Pre-exposure Prophylaxis Post-exposure Prophylaxis
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Rabies Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Rabies Vaccine - Market size in 2030?

Ans: The Rabies Vaccine - Market size in 2030 will be US$ 1229.1 million.

What is the market share of major companies in Rabies Vaccine - Market?

Ans: Global top four manufacturers hold a share about 70%.

What is the Rabies Vaccine - Market share by type?

Ans: In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%.

Who are the main players in the Rabies Vaccine - Market report?

Ans: The main players in the Rabies Vaccine - Market are GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen

What are the Application segmentation covered in the Rabies Vaccine - Market report?

Ans: The Applications covered in the Rabies Vaccine - Market report are Pre-exposure Prophylaxis, Post-exposure Prophylaxis

What are the Type segmentation covered in the Rabies Vaccine - Market report?

Ans: The Types covered in the Rabies Vaccine - Market report are Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Others

1 Market Overview

1.1 Rabies Vaccine Product Introduction

1.2 Global Rabies Vaccine Market Size Forecast

1.2.1 Global Rabies Vaccine Sales Value (2019-2030)

1.2.2 Global Rabies Vaccine Sales Volume (2019-2030)

1.2.3 Global Rabies Vaccine Sales Price (2019-2030)

1.3 Rabies Vaccine Market Trends & Drivers

1.3.1 Rabies Vaccine Industry Trends

1.3.2 Rabies Vaccine Market Drivers & Opportunity

1.3.3 Rabies Vaccine Market Challenges

1.3.4 Rabies Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Rabies Vaccine Players Revenue Ranking (2023)

2.2 Global Rabies Vaccine Revenue by Company (2019-2024)

2.3 Global Rabies Vaccine Players Sales Volume Ranking (2023)

2.4 Global Rabies Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Rabies Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Rabies Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Rabies Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Rabies Vaccine

2.9 Rabies Vaccine Market Competitive Analysis

2.9.1 Rabies Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Rabies Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Vero Cell Rabies Vaccine

3.1.2 BHK

3.1.3 Chick Embryo Cell Rabies Vaccine

3.1.4 Others

3.2 Global Rabies Vaccine Sales Value by Type

3.2.1 Global Rabies Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Rabies Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Rabies Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Rabies Vaccine Sales Volume by Type

3.3.1 Global Rabies Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Rabies Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Rabies Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Rabies Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pre-exposure Prophylaxis

4.1.2 Post-exposure Prophylaxis

4.2 Global Rabies Vaccine Sales Value by Application

4.2.1 Global Rabies Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Rabies Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Rabies Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Rabies Vaccine Sales Volume by Application

4.3.1 Global Rabies Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Rabies Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Rabies Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Rabies Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Rabies Vaccine Sales Value by Region

5.1.1 Global Rabies Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Rabies Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Rabies Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Rabies Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Rabies Vaccine Sales Volume by Region

5.2.1 Global Rabies Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Rabies Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Rabies Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Rabies Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Rabies Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Rabies Vaccine Sales Value, 2019-2030

5.4.2 North America Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Rabies Vaccine Sales Value, 2019-2030

5.5.2 Europe Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Rabies Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Rabies Vaccine Sales Value, 2019-2030

5.7.2 South America Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Rabies Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Rabies Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Rabies Vaccine Sales Value

6.2.1 Key Countries/Regions Rabies Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Rabies Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Rabies Vaccine Sales Value, 2019-2030

6.3.2 United States Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Rabies Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Rabies Vaccine Sales Value, 2019-2030

6.4.2 Europe Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Rabies Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Rabies Vaccine Sales Value, 2019-2030

6.5.2 China Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Rabies Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Rabies Vaccine Sales Value, 2019-2030

6.6.2 Japan Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Rabies Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Rabies Vaccine Sales Value, 2019-2030

6.7.2 South Korea Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Rabies Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Rabies Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Rabies Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Rabies Vaccine Sales Value, 2019-2030

6.9.2 India Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Rabies Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GSK (Novartis)

7.1.1 GSK (Novartis) Company Information

7.1.2 GSK (Novartis) Introduction and Business Overview

7.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GSK (Novartis) Rabies Vaccine Product Offerings

7.1.5 GSK (Novartis) Recent Development

7.2 Sanofi-Pasteur

7.2.1 Sanofi-Pasteur Company Information

7.2.2 Sanofi-Pasteur Introduction and Business Overview

7.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sanofi-Pasteur Rabies Vaccine Product Offerings

7.2.5 Sanofi-Pasteur Recent Development

7.3 Chengda

7.3.1 Chengda Company Information

7.3.2 Chengda Introduction and Business Overview

7.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Chengda Rabies Vaccine Product Offerings

7.3.5 Chengda Recent Development

7.4 Yisheng

7.4.1 Yisheng Company Information

7.4.2 Yisheng Introduction and Business Overview

7.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Yisheng Rabies Vaccine Product Offerings

7.4.5 Yisheng Recent Development

7.5 Prcmise

7.5.1 Prcmise Company Information

7.5.2 Prcmise Introduction and Business Overview

7.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Prcmise Rabies Vaccine Product Offerings

7.5.5 Prcmise Recent Development

7.6 VACN

7.6.1 VACN Company Information

7.6.2 VACN Introduction and Business Overview

7.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 VACN Rabies Vaccine Product Offerings

7.6.5 VACN Recent Development

7.7 Changsheng

7.7.1 Changsheng Company Information

7.7.2 Changsheng Introduction and Business Overview

7.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Changsheng Rabies Vaccine Product Offerings

7.7.5 Changsheng Recent Development

7.8 BCHT

7.8.1 BCHT Company Information

7.8.2 BCHT Introduction and Business Overview

7.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 BCHT Rabies Vaccine Product Offerings

7.8.5 BCHT Recent Development

7.9 Hissen

7.9.1 Hissen Company Information

7.9.2 Hissen Introduction and Business Overview

7.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Hissen Rabies Vaccine Product Offerings

7.9.5 Hissen Recent Development

8 Industry Chain Analysis

8.1 Rabies Vaccine Industrial Chain

8.2 Rabies Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Rabies Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Rabies Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Rabies Vaccine Market Trends

Table 2. Rabies Vaccine Market Drivers & Opportunity

Table 3. Rabies Vaccine Market Challenges

Table 4. Rabies Vaccine Market Restraints

Table 5. Global Rabies Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Rabies Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Rabies Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Rabies Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Rabies Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Rabies Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Rabies Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Rabies Vaccine

Table 13. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Rabies Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Rabies Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Rabies Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Rabies Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Rabies Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Rabies Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Rabies Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Rabies Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Rabies Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Rabies Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Rabies Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Rabies Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Rabies Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Rabies Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Rabies Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Rabies Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Rabies Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Rabies Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Rabies Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Rabies Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Rabies Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Rabies Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Rabies Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Rabies Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Rabies Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Rabies Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Rabies Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Rabies Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Rabies Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Rabies Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Rabies Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Rabies Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Rabies Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Rabies Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Rabies Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Rabies Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Rabies Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Rabies Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Rabies Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Rabies Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Rabies Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. GSK (Novartis) Company Information

Table 58. GSK (Novartis) Introduction and Business Overview

Table 59. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. GSK (Novartis) Rabies Vaccine Product Offerings

Table 61. GSK (Novartis) Recent Development

Table 62. Sanofi-Pasteur Company Information

Table 63. Sanofi-Pasteur Introduction and Business Overview

Table 64. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Sanofi-Pasteur Rabies Vaccine Product Offerings

Table 66. Sanofi-Pasteur Recent Development

Table 67. Chengda Company Information

Table 68. Chengda Introduction and Business Overview

Table 69. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Chengda Rabies Vaccine Product Offerings

Table 71. Chengda Recent Development

Table 72. Yisheng Company Information

Table 73. Yisheng Introduction and Business Overview

Table 74. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Yisheng Rabies Vaccine Product Offerings

Table 76. Yisheng Recent Development

Table 77. Prcmise Company Information

Table 78. Prcmise Introduction and Business Overview

Table 79. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Prcmise Rabies Vaccine Product Offerings

Table 81. Prcmise Recent Development

Table 82. VACN Company Information

Table 83. VACN Introduction and Business Overview

Table 84. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. VACN Rabies Vaccine Product Offerings

Table 86. VACN Recent Development

Table 87. Changsheng Company Information

Table 88. Changsheng Introduction and Business Overview

Table 89. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Changsheng Rabies Vaccine Product Offerings

Table 91. Changsheng Recent Development

Table 92. BCHT Company Information

Table 93. BCHT Introduction and Business Overview

Table 94. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. BCHT Rabies Vaccine Product Offerings

Table 96. BCHT Recent Development

Table 97. Hissen Company Information

Table 98. Hissen Introduction and Business Overview

Table 99. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Hissen Rabies Vaccine Product Offerings

Table 101. Hissen Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Rabies Vaccine Downstream Customers

Table 105. Rabies Vaccine Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Rabies Vaccine Product Picture

Figure 2. Global Rabies Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Rabies Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Rabies Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Rabies Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Rabies Vaccine Report Years Considered

Figure 7. Global Rabies Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Rabies Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Rabies Vaccine Revenue in 2023

Figure 10. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Vero Cell Rabies Vaccine Picture

Figure 12. BHK Picture

Figure 13. Chick Embryo Cell Rabies Vaccine Picture

Figure 14. Others Picture

Figure 15. Global Rabies Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Rabies Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Rabies Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Rabies Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Rabies Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 20. Product Picture of Pre-exposure Prophylaxis

Figure 21. Product Picture of Post-exposure Prophylaxis

Figure 22. Global Rabies Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Rabies Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Rabies Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Rabies Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Rabies Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 27. North America Rabies Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Rabies Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Rabies Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Rabies Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Rabies Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Rabies Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Rabies Vaccine Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Rabies Vaccine Sales Volume (%), (2019-2030)

Figure 39. United States Rabies Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Rabies Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Rabies Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Rabies Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 45. China Rabies Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 47. China Rabies Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Rabies Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Rabies Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Rabies Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Rabies Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Rabies Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Rabies Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 57. India Rabies Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Rabies Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 59. India Rabies Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 60. Rabies Vaccine Industrial Chain

Figure 61. Rabies Vaccine Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions